Literature DB >> 19220592

Childhood developmental disorders: an academic and clinical convergence point for psychiatry, neurology, psychology and pediatrics.

Allan L Reiss1.   

Abstract

BACKGROUND: Significant advances in understanding brain development and behavior have not been accompanied by revisions of traditional academic structure. Disciplinary isolation and a lack of meaningful interdisciplinary opportunities are persistent barriers in academic medicine. To enhance clinical practice, research, and training for the next generation, academic centers will need to take bold steps that challenge traditional departmental boundaries. Such change is not only desirable but, in fact, necessary to bring about a truly innovative and more effective approach to treating disorders of the developing brain.
METHODS: I focus on developmental disorders as a convergence point for transcending traditional academic boundaries. First, the current taxonomy of developmental disorders is described with emphasis on how current diagnostic systems inadvertently hinder research progress. Second, I describe the clinical features of autism, a phenomenologically defined condition, and Rett and fragile X syndromes, neurogenetic diseases that are risk factors for autism. Finally, I describe how the fields of psychiatry, psychology, neurology, and pediatrics now have an unprecedented opportunity to promote an interdisciplinary approach to training, research, and clinical practice and, thus, advance a deeper understanding of developmental disorders.
RESULTS: Research focused on autism is increasingly demonstrating the heterogeneity of individuals diagnosed by DSM criteria. This heterogeneity hinders the ability of investigators to replicate research results as well as progress towards more effective, etiology-specific interventions. In contrast, fragile X and Rett syndromes are 'real' diseases for which advances in research are rapidly accelerating towards more disease-specific human treatment trials.
CONCLUSIONS: A major paradigm shift is required to improve our ability to diagnose and treat individuals with developmental disorders. This paradigm shift must take place at all levels - training, research and clinical activity. As clinicians and scientists who are currently constrained by disciplinary-specific history and training, we must move towards redefining ourselves as clinical neuroscientists with shared interests and expertise that permit a more cohesive and effective approach to improving the lives of patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220592      PMCID: PMC5756732          DOI: 10.1111/j.1469-7610.2008.02046.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  45 in total

Review 1.  A perspective on the research literature related to early intensive behavioral intervention (Lovaas) for young children with autism.

Authors:  Victoria Shea
Journal:  Autism       Date:  2004-12

Review 2.  Fragile X syndrome: assessment and treatment implications.

Authors:  Allan L Reiss; Scott S Hall
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2007-07

Review 3.  Developmental dyslexia: an update on genes, brains, and environments.

Authors:  E L Grigorenko
Journal:  J Child Psychol Psychiatry       Date:  2001-01       Impact factor: 8.982

4.  Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society.

Authors:  P A Filipek; P J Accardo; S Ashwal; G T Baranek; E H Cook; G Dawson; B Gordon; J S Gravel; C P Johnson; R J Kallen; S E Levy; N J Minshew; S Ozonoff; B M Prizant; I Rapin; S J Rogers; W L Stone; S W Teplin; R F Tuchman; F R Volkmar
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

5.  Compulsive, self-injurious, and autistic behavior in children and adolescents with fragile X syndrome.

Authors:  Scott S Hall; Amy A Lightbody; Allan L Reiss
Journal:  Am J Ment Retard       Date:  2008-01

Review 6.  The neuroanatomy and neuroendocrinology of fragile X syndrome.

Authors:  David Hessl; Susan M Rivera; Allan L Reiss
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2004

Review 7.  Dynamic mutation and human disorders: the spinocerebellar ataxias (review).

Authors:  Marcelo Aguiar Costa Lima; Marcia Mattos Gonçalves Pimentel
Journal:  Int J Mol Med       Date:  2004-02       Impact factor: 4.101

Review 8.  Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines.

Authors:  Elizabeth Berry-Kravis; Liane Abrams; Sarah M Coffey; Deborah A Hall; Claudia Greco; Louise W Gane; Jim Grigsby; James A Bourgeois; Brenda Finucane; Sebastien Jacquemont; James A Brunberg; Lin Zhang; Janet Lin; Flora Tassone; Paul J Hagerman; Randi J Hagerman; Maureen A Leehey
Journal:  Mov Disord       Date:  2007-10-31       Impact factor: 10.338

Review 9.  Fragile X and reproduction.

Authors:  J Ryan Martin; Aydin Arici
Journal:  Curr Opin Obstet Gynecol       Date:  2008-06       Impact factor: 1.927

Review 10.  Clinical variability in Rett syndrome.

Authors:  SakkuBai Naidu; Genila Bibat; Lisa Kratz; Richard I Kelley; Jonathan Pevsner; Eric Hoffman; Carmen Cuffari; Charles Rohde; Mary E Blue; Michael V Johnston
Journal:  J Child Neurol       Date:  2003-10       Impact factor: 1.987

View more
  19 in total

1.  Autism in fragile X syndrome: a category mistake?

Authors:  Scott S Hall; Amy A Lightbody; Melissa Hirt; Ava Rezvani; Allan L Reiss
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-08-01       Impact factor: 8.829

Review 2.  Imaging-genetics applications in child psychiatry.

Authors:  Daniel S Pine; Monique Ernst; Ellen Leibenluft
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-04-09       Impact factor: 8.829

3.  A 'learning platform' approach to outcome measurement in fragile X syndrome: a preliminary psychometric study.

Authors:  S S Hall; J L Hammond; M Hirt; A L Reiss
Journal:  J Intellect Disabil Res       Date:  2012-04-25

4.  Autism is a Portmanteau syndrome.

Authors:  Lynn Waterhouse
Journal:  Neuropsychol Rev       Date:  2009-05-26       Impact factor: 7.444

Review 5.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

6.  Receptor Tyrosine Kinase MET Interactome and Neurodevelopmental Disorder Partners at the Developing Synapse.

Authors:  Zhihui Xie; Jing Li; Jonathan Baker; Kathie L Eagleson; Marcelo P Coba; Pat Levitt
Journal:  Biol Psychiatry       Date:  2016-02-26       Impact factor: 13.382

Review 7.  Stem cells and modeling of autism spectrum disorders.

Authors:  Beatriz C G Freitas; Cleber A Trujillo; Cassiano Carromeu; Marianna Yusupova; Roberto H Herai; Alysson R Muotri
Journal:  Exp Neurol       Date:  2012-10-02       Impact factor: 5.330

Review 8.  Gene, brain, and behavior relationships in fragile X syndrome: evidence from neuroimaging studies.

Authors:  Amy A Lightbody; Allan L Reiss
Journal:  Dev Disabil Res Rev       Date:  2009

9.  Identifying large-scale brain networks in fragile X syndrome.

Authors:  Scott S Hall; Heidi Jiang; Allan L Reiss; Michael D Greicius
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

10.  A Cross-Disorder Method to Identify Novel Candidate Genes for Developmental Brain Disorders.

Authors:  Andrea J Gonzalez-Mantilla; Andres Moreno-De-Luca; David H Ledbetter; Christa Lese Martin
Journal:  JAMA Psychiatry       Date:  2016-03       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.